Technology versus products – what’s the real driving force of interest for the pharmaceutical industry?

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.1, Iss.1, 2004-11, pp. : 1-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Financial Risk of the Biotech Industry versus the Pharmaceutical Industry

By Golec Joseph Vernon John A.

Applied Health Economics and Health Policy, Vol. 7, Iss. 3, 2009-09 ,pp. : 155-165

Adis International

Access to resources Recommend Favorite

The importance of the pharmaceutical industry to the UK economy

By Earl-Slater Alan

Journal of Management in Medicine, Vol. 12, Iss. 1, 1998-01 ,pp. : 5-20

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Citrus limon: a source of flavonoids of pharmaceutical interest

By Del Rio J.A. Fuster M.D. Gomez P. Porras I. Garcia-Lidon A. Ortuno A.

Food Chemistry, Vol. 84, Iss. 3, 2004-02 ,pp. : 457-461

Elsevier

Access to resources Recommend Favorite

Sensemaking: a driving force behind the integration of professional practices

By Sylvain Chantal Lamothe Lise

Journal of Health, Organisation and Management, Vol. 26, Iss. 6, 2012-10 ,pp. : 737-757

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Quality management benchmarking: FDA compliance in pharmaceutical industry

By Jochem Roland Landgraf Katja

International Journal of Health Care Quality Assurance, Vol. 23, Iss. 8, 2010-10 ,pp. : 690-698

Emerald Group Publishing Ltd

Access to resources Recommend Favorite